Literature DB >> 12418364

Analytic framework for clinician provision of end-of-life care.

Grace Johnston1, Frederick Burge.   

Abstract

Four dimensions for the provision of end-of-life care by clinicians were identified from a review and synthesis of the Canadian family physician and palliative care literatures. These dimensions are: clinician-patient continuity, timing and location of care, community-centred services, and multidisciplinary care. Indicators of each dimension are presented along with criteria for indicator selection. The analytic framework was refined during the linkage of population-based administrative databases to identify patterns of family physician service provision in the last months of life for persons dying from cancer in Nova Scotia, Canada. Data analysis was framed to inform palliative care policy and programs, as well as to enable comparison among geographic areas within and beyond Canada.

Entities:  

Mesh:

Year:  2002        PMID: 12418364

Source DB:  PubMed          Journal:  J Palliat Care        ISSN: 0825-8597            Impact factor:   2.250


  3 in total

1.  Towards using administrative databases to measure population-based indicators of quality of end-of-life care: testing the methodology.

Authors:  Eva Grunfeld; Lynn Lethbridge; Ron Dewar; Beverley Lawson; Lawrence F Paszat; Grace Johnston; Frederick Burge; Paul McIntyre; Craig C Earle
Journal:  Palliat Med       Date:  2006-12       Impact factor: 4.762

2.  Can the introduction of an integrated service model to an existing comprehensive palliative care service impact emergency department visits among enrolled patients?

Authors:  Beverley J Lawson; Frederick I Burge; Paul McIntyre; Simon Field; David Maxwell
Journal:  J Palliat Med       Date:  2009-03       Impact factor: 2.947

3.  Toward population-based indicators of quality end-of-life care: testing stakeholder agreement.

Authors:  Eva Grunfeld; Robin Urquhart; Eric Mykhalovskiy; Amy Folkes; Grace Johnston; Frederick I Burge; Craig C Earle; Susan Dent
Journal:  Cancer       Date:  2008-05-15       Impact factor: 6.860

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.